OR51A9P

Across TCGA pan-cancer cohorts, OR51A9P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR51A9P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR51A9P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR51A9P is over-expressed in tumor.

KIRC, PRAD, and BRCA are the cancer types where OR51A9P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR51A9P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.075	<.001	10	view →
PRAD	All	All	+1.571	<.001	2	view →
BRCA	All	II,III,IV	+0.016	.035	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR51A9P–KIRC

Open the KIRC breakdown →